Literature DB >> 30305295

What treatments are effective for common cold in adults and children?

Mieke L van Driel1, Sophie Scheire2, Laura Deckx3, Philippe Gevaert4, An De Sutter5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30305295     DOI: 10.1136/bmj.k3786

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey.

Authors:  Margaux Lafaurie; Pascale Olivier; Charles Khouri; Marina Atzenhoffer; Kévin Bihan; Geneviève Durrieu; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2019-12-20       Impact factor: 2.953

2.  Traditional medicine for the treatment of common cold in Korean adults: A nationwide population-based study.

Authors:  Hyungtae Kim; Jun-Yong Choi; Minna Hong; Hae Sun Suh
Journal:  Integr Med Res       Date:  2020-06-24

3.  Tuina for children with upper respiratory tract infections: A protocol for a systematic review.

Authors:  Jiayuan Zhang; Yunhui Chen; Liu Cao; Renyan Zhang; Renyuan Ren; Qi Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Nasal saline irrigation: prescribing habits and attitudes of physicians and pharmacists.

Authors:  Jesse Tapiala; Antti Hyvärinen; Sanna Toppila-Salmi; Eero Suihko; Elina Penttilä
Journal:  Scand J Prim Health Care       Date:  2021-02-11       Impact factor: 2.581

5.  Pharmacist's recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland.

Authors:  Malgorzata Pietrusiewicz; Paulina Natalia Kopa-Stojak; Rafal Pawliczak
Journal:  BMC Fam Pract       Date:  2021-10-30       Impact factor: 2.497

6.  Observational study investigating Ectoin® Rhinitis Nasal Spray as natural treatment option of acute rhinosinusitis compared to treatment with Xylometazoline.

Authors:  Nina Werkhäuser; Andreas Bilstein; Kathrin Mahlstedt; Uwe Sonnemann
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-04       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.